Tree man syndrome, or epidermodysplasia verruciformis (EV), is a rare, incurable skin disorder that makes people highly susceptible to human papillomavirus (HPV) infection. The disease can lead to ...

A disturbing trend has emerged where AI is being used to create Instagram influencers with Down syndrome to promote adult content on platforms like OnlyFans and Fanvue. This practice, which ...

Mast cell activation syndrome, or disease (MCAS), is a condition that causes mast cells to release these substances too frequently, resulting in severe allergic reactions. After detecting an ...

which stands for myalgic encephalomyelitis/chronic fatigue syndrome. “The field of ME/CFS is ripe for clinical trials,” Lipkin, who directs the center, told Fierce Biotech in a March 19 interview.

Though the exact mechanism of action is unclear, it is believed that in patients with Prader-Willi syndrome, diazoxide choline reduces hyperphagia through activation of the adenosine triphosphate ...

Since 2000, when the FDA approved recombinant human growth hormone (rhGH) for those with the rare genetic disorder Prader-Willi Syndrome (PWS), several companies have come up short in their ...

Mercado, like many immigrants, experienced what’s known as Ulysses syndrome. “I always wanted this, but maybe it wasn’t what I was expecting,” he said. “But I was already here ...

extended-release tablets for treating hyperphagia in adults and children aged four years and older with Prader-Willi syndrome (PWS). The company expects to launch the drug in the United States in ...

You’ve fooled everyone. And soon they’ll all find out.” Welcome to imposter syndrome, that maddening psychological phenomenon where despite clear evidence of your competence, you remain ...

March 27, 2025 – The FDA has approved a drug to treat a key symptom of a rare life-threatening genetic disorder known as Prader-Willi syndrome (PWS) in adults and children ages 4 or older.

The US Food and Drug Administration (FDA) has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release tablets as the first treatment to address hyperphagia in patients with the ...